EUVIMEDAtrasti EUVIMED
EUVIMED · CrossrefJournal

International Journal of Experimental and Biomedical Research

ISSN 2583-5254 · GP Innovations Pvt. Ltd.

Latest articles

  1. Inflammatory Bowel Disease Signal Associated with Dipeptidyl Peptidase - 4 Inhibitor Exposure in Type 2 Diabetes Mellitus: A Retrospective Case – Control Study from a Tertiary Care Hospital

    {"name":"Guddanti Rajasree","email":"shalinichevuru99@gmail.com","affiliation", {"name":"Katteti pujitha","email":"shalinichevuru99@gmail.com","affiliation":, {"name":"Kommala pravallika","email":"shalinichevuru99@gmail.com","affiliatio, {"name":"Shaik shabna","email":"shalinichevuru99@gmail.com","affiliation":", {"name":"Shaik Nawaz","email":"shalinichevuru99@gmail.com","affiliation":"I, {"name":"Chevuru Baby Shalini","email":"shalinichevuru99@gmail.com","affiliat, {"name":"Yadala prapurna chandra","email":"shalinichevuru99@gmail.com","affi

    Published: 2026-04-16DOI: 10.26452/ijebr.v5i2.571

  2. Formulation and characterization of sevelamer carbonate immediate release tablets

    {"name":"Vadamala Prudhvi Raj","email":"prudhvirajpharma9@gmail.com","affiliat, {"name":"L G Chaithra","email":"prudhvirajpharma9@gmail.com","affiliati, {"name":"P Mounika","email":"prudhvirajpharma9@gmail.com","affiliation", {"name":"M Naga Gouthami","email":"prudhvirajpharma9@gmail.com","affili, {"name":"C Swapna","email":"prudhvirajpharma9@gmail.com","affiliation":, {"name":"D Vandana","email":"prudhvirajpharma9@gmail.com","affiliation", {"name":"Y Jagadeesh","email":"prudhvirajpharma9@gmail.com","affiliatio, {"name":"M Niranjan Babu","email":"prudhvirajpharma9@gmail.com","affili

    Published: 2026-04-02DOI: 10.26452/ijebr.v5i2.552

  3. Formulation And Evaluation of Herbal Anti - Pollution Cream

    {"name":"Yelamanda Jagadeesh","email":"jagadeeshlakshmi.16@gmail.com","affiliat, {"name":"M.V. Bhavya Sree","email":"jagadeeshlakshmi.16@gmail.com","affili, {"name":"G. Lekya","email":"jagadeeshlakshmi.16@gmail.com","affiliation", {"name":"K. Sumithra","email":"jagadeeshlakshmi.16@gmail.com","affiliati, {"name":"V. Ganesh Naik","email":"jagadeeshlakshmi.16@gmail.com","affili, {"name":"G. Uday Kumar","email":"jagadeeshlakshmi.16@gmail.com","affilia, {"name":"Prudhvi Raj Vadamala","email":"jagadeeshlakshmi.16@gmail.com","affil, {"name":"M Niranjan Babu","email":"jagadeeshlakshmi.16@gmail.com","affi

    Published: 2026-03-24DOI: 10.26452/ijebr.v5i2.576

  4. An overview on T - cells and regulatory cells

    {"name":"Salma Shaik","email":"salma.mpharm@gmail.com","affiliation":"Depar, {"name":"Lalitha Chembeti","email":"salma.mpharm@gmail.com","affiliation":"De, {"name":"S Naga bharathi","email":"salma.mpharm@gmail.com","affiliation, {"name":"G. Jahnavi","email":"salma.mpharm@gmail.com","affiliation":"Nar, {"name":"SK. Yasmeen","email":"salma.mpharm@gmail.com","affiliation":"Nar, {"name":"K. Nikitha","email":"salma.mpharm@gmail.com","affiliation":"Nar, {"name":"CH. Hasritha","email":"salma.mpharm@gmail.com","affiliation":"Na, {"name":"B. Sravani","email":"salma.mpharm@gmail.com","affiliation":"Nar, {"name":"Munna Sreenivasulu","email":"salma.mpharm@gmail.com","affiliation"

    Published: 2026-01-04DOI: 10.26452/ijebr.v5i1.543

  5. Formulation and Evaluation of Capecitabine Loaded Proniosomes

    {"name":"Bijapuri Srivastava","email":"srisays2u@gmail.com","affiliation":"Dep, {"name":"Sonypriya B","email":"srisays2u@gmail.com","affiliation":"St. Mary’s G, {"name":"Muthamsetty Sravani","email":"srisays2u@gmail.com","affiliation":"St. Ma, {"name":"Athmakuri Thabitharani","email":"srisays2u@gmail.com","affiliation":"S, {"name":"Kota Lakshmi Veda Manasa","email":"srisays2u@gmail.com","affiliat

    Published: 2022-04-01DOI: 10.26452/ijebr.v1i2.372

  6. Herbal Remedies as a Treatment of Breast Cancer

    {"name":"Praveen Gujjula","email":"praveen.pharma33@gmail.com","affiliation":, {"name":"Shaganti Gayathri","email":"praveen.pharma33@gmail.com","affiliation", {"name":"Potlapalli Sai Sushma","email":"praveen.pharma33@gmail.com","affiliatio, {"name":"Pallati Vaishnavi Netha","email":"praveen.pharma33@gmail.com","affil

    Published: 2022-04-01DOI: 10.26452/ijebr.v1i2.374

  7. Formulation and Evaluation of a pH Induced In Situ Occular Gelling System of Ketorolac

    {"name":"Sravya B","email":"dureddysravya@gmail.com","affiliation":"Departme, {"name":"Mandalapu Ruchitha","email":"dureddysravya@gmail.com","affiliation":"S, {"name":"Kankala Soujanya","email":"dureddysravya@gmail.com","affiliation":"S, {"name":"Nimmala Raveena","email":"dureddysravya@gmail.com","affiliation":"St, {"name":"Syed Ahmed Hussaini","email":"dureddysravya@gmail.com","affiliati, {"name":"Modugula Jayaram","email":"dureddysravya@gmail.com","affiliation":"St

    Published: 2022-04-01DOI: 10.26452/ijebr.v1i2.376

  8. Review on Microspheres, and its Characterisation of Various Drugs

    {"name":"Swathi Krishna K V","email":"swathikrishna004@gmail.com","affiliati, {"name":"Sainath H","email":"swathikrishna004@gmail.com","affiliation":"Depar, {"name":"Bhanu Prakash R","email":"swathikrishna004@gmail.com","affiliation, {"name":"Rajeswari K","email":"swathikrishna004@gmail.com","affiliation":"Depar, {"name":"Pavithra G","email":"swathikrishna004@gmail.com","affiliation":"Depar, {"name":"Bhuvaneswari G","email":"swathikrishna004@gmail.com","affiliation":"Depar, {"name":"Jaya Prakash K","email":"swathikrishna004@gmail.com","affiliation

    Published: 2022-04-01DOI: 10.26452/ijebr.v1i2.377

  9. Review on Recent Diseases Caused by Microbes

    {"name":"Theladala Manasa","email":"manasayadavtheladala@gmail.com","affiliatio, {"name":"Kanupuru Vyshnavi","email":"manasayadavtheladala@gmail.com","affiliat, {"name":"Penaka Nomika Reddy","email":"manasayadavtheladala@gmail.com","affi, {"name":"Sreenivasulu M","email":"manasayadavtheladala@gmail.com","affiliation":"D

    Published: 2022-04-01DOI: 10.26452/ijebr.v1i2.381

  10. Formulation and Evaluation of Nitrofurantoin Microspheres Loaded in Hard Gelatin Capsule

    {"name":"Madhuri Reddy M","email":"madhurireddy.62@gmail.com","affiliation":", {"name":"Gundala Deepika","email":"madhurireddy.62@gmail.com","affiliation":", {"name":"Meesala Simon","email":"madhurireddy.62@gmail.com","affiliation":"St, {"name":"Pothireddy Bharat","email":"madhurireddy.62@gmail.com","affiliation":"S, {"name":"Golam Soϐiullah SK","email":"madhurireddy.62@gmail.com","affiliati, {"name":"Addakula Varalaxmi","email":"madhurireddy.62@gmail.com","affiliation"

    Published: 2022-01-01DOI: 10.26452/ijebr.v1i1.366

  11. A Case Report of Acute Liver Failure due to Hemophagocytic Lymphohistiocytosis

    {"name":"Boini Meghana","email":"sweetymeghana191@gmail.com","affiliation":, {"name":"Chimata Manisha","email":"sweetymeghana191@gmail.com","affiliation":, {"name":"Shaik Sana","email":"sweetymeghana191@gmail.com","affiliation":"St, {"name":"Bhura Akhila","email":"sweetymeghana191@gmail.com","affiliation":", {"name":"Jettegalla Sandhya Rani","email":"sweetymeghana191@gmail.com","affiliat, {"name":"Naragoni Shireesha","email":"sweetymeghana191@gmail.com","affiliation

    Published: 2022DOI: 10.26452/ijebr.v1i1.363

  12. Case Report on a Dimorphic Fungal Disease - Blastomycosis

    {"name":"Masinamoni Sravani","email":"machanamonisravani867@gmail.com","affiliat, {"name":"Mudedla Hasini","email":"machanamonisravani867@gmail.com","affiliati, {"name":"Patha Bhargavi","email":"machanamonisravani867@gmail.com","affilia, {"name":"Eluduti Himabindu","email":"machanamonisravani867@gmail.com","affili, {"name":"Alli Sowjanya","email":"machanamonisravani867@gmail.com","affilia, {"name":"Nakarakanti Navya","email":"machanamonisravani867@gmail.com","affiliatio

    Published: 2022DOI: 10.26452/ijebr.v1i1.364

Volumes

2026 · 112025 · 192024 · 242023 · 192022 · 222021 · 1

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.